BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 19476578)

  • 1. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting coronary artery stents.
    Dehmer GJ; Smith KJ
    Am Fam Physician; 2009 Dec; 80(11):1245-51. PubMed ID: 19961137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
    Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.
    Acharjee S; Cannon CP
    Crit Pathw Cardiol; 2010 Dec; 9(4):203-6. PubMed ID: 21119338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
    Sharma A; Berkeley A
    J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
    Gurbel PA; DiChiara J; Tantry US
    Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of bare metal stent in drug eluting stent era].
    Takizawa K; Inoue N
    Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy.
    Gurbel PA; Tantry US
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S19-26. PubMed ID: 17401307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative management of the patient with a coronary stent.
    Popescu WM
    Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late coronary stent thrombosis complicating urologic surgery.
    de Korte FI; van Werkum JW; Vijverberg PL; Ten Berg JM
    Eur Urol; 2008 Jul; 54(1):221-5; quiz 225. PubMed ID: 17964710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.